Precision medicine is revolutionizing the landscape of cancer diagnosis, prognosis, and therapy by tailoring treatment strategies to the unique genetic, molecular, and environmental characteristics of individual patients. This chapter explores the most promising breakthroughs that are redefining cancer care, including advances in multi-omics integration, liquid biopsy technologies, artificial intelligence (AI)–driven diagnostics, and next-generation targeted therapies. We delve into the clinical impact of CRISPR-based gene editing, tumor microenvironment modulation, and personalized immunotherapies such as neoantigen vaccines and CAR-T cell platforms. The chapter also highlights current limitations—such as tumor heterogeneity, resistance mechanisms, and disparities in biomarker access—and outlines future research priorities aimed at addressing these challenges. These include the development of dynamic biomarkers, improved patient stratification models, and global data-sharing frameworks. By examining both current innovations and future trajectories, this chapter provides a comprehensive outlook on how precision medicine is poised to transform oncology from reactive care to proactive and predictive intervention.